LON:BPCRBiopharma Credit Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Biopharma Credit PLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 0.99 0.00 (0.00 %) (As of 07/15/2020 01:35 AM ET) Add Compare Share Today's Range 0.99Now: GBX 0.99▼ 150-Day Range 0.95MA: GBX 0.97▼ 0.9952-Week Range 0.70Now: GBX 0.99▼ 1.06Volume232,301 shsAverage Volume64,237 shsMarket Capitalization£13.66 millionP/E Ratio10.57Dividend Yield6.90%BetaN/A ProfileAdvanced ChartCompetitorsDividendInsider TradesHeadlines BioPharma Credit PLC, an investment trust, invests in interest-bearing debt assets secured by royalties or other cash flows derived from the royalties and sales of life sciences products. The company was incorporated in 2016 and is based in Exeter, the United Kingdom.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Biopharma Credit. Previous Next 2.4 Community Rank Outperform VotesBiopharma Credit has received 84 “outperform” votes. (Add your “outperform” vote.)Underperform VotesBiopharma Credit has received 93 “underperform” votes. (Add your “underperform” vote.)Community SentimentBiopharma Credit has received 52.54% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Biopharma Credit and other stocks. Vote “Outperform” if you believe BPCR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BPCR will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 2.5 Dividend Strength Dividend LeadershipBiopharma Credit is a leading dividend payer. It pays a dividend yield of 6.90%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthBiopharma Credit does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Biopharma Credit is 74.47%. This payout ratio is at a healthy, sustainable level, below 75%. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Biopharma Credit insiders have not sold or bought any company stock. Previous Next 1.9 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Biopharma Credit is 10.57, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 16.73.Price to Earnings Ratio vs. SectorThe P/E ratio of Biopharma Credit is 10.57, which means that it is trading at a less expensive P/E ratio than the Financial Services sector average P/E ratio of about 12.82.Price to Book Value per Share RatioBiopharma Credit has a P/B Ratio of 0.01. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.36 out of 5 stars Industry, Sector and Symbol Stock Exchange LON Industry Asset Management Sub-IndustryN/A SectorFinancial Services Current SymbolLON:BPCR Previous Symbol CUSIPN/A CIKN/A Webwww.bpcruk.com PhoneN/ADebt Debt-to-Equity RatioN/A Current Ratio158.85 Quick Ratio158.85Price-To-Earnings Trailing P/E Ratio10.57 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales£141.97 million Price / Sales0.10 Cash FlowGBX 44.38 per share Price / Cash Flow0.02 Book ValueGBX 102.60 per share Price / Book0.01Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares1,373,929,984Market Cap£13.66 million Next Earnings DateN/A OptionableNot Optionable LSE:BPCR Rates by TradingView Receive BPCR News and Ratings via Email Sign-up to receive the latest news and ratings for BPCR and its competitors with MarketBeat's FREE daily newsletter. Biopharma Credit (LON:BPCR) Frequently Asked Questions How has Biopharma Credit's stock been impacted by COVID-19 (Coronavirus)? Biopharma Credit's stock was trading at GBX 0.98 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BPCR shares have increased by 1.0% and is now trading at GBX 0.99. View which stocks have been most impacted by Coronavirus. How often does Biopharma Credit pay dividends? What is the dividend yield for Biopharma Credit? Biopharma Credit announced a dividend on Thursday, May 14th. Investors of record on Thursday, May 21st will be given a dividend of GBX 0.02 per share on Friday, June 19th. This represents a dividend yield of 1.82%. The ex-dividend date of this dividend is Thursday, May 21st. The official announcement can be accessed at this link. View Biopharma Credit's dividend history. Has Biopharma Credit been receiving favorable news coverage? News headlines about BPCR stock have trended somewhat positive on Wednesday, according to InfoTrie Sentiment. The research firm identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Biopharma Credit earned a media sentiment score of 2.0 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company's share price in the near future. View the latest news about Biopharma Credit. Who are some of Biopharma Credit's key competitors? Some companies that are related to Biopharma Credit include Mobeus Income & Growth VCT (MIX), BMO MANA/PAR VTG FPD 0.1 (BMPI), INVO PERP/PAR VTG FPD 0.01 (IVPG), DIVIDEND 15 SPLIT II CL A (DF), Contrarian Value Fund (CVF), Mainstream Group (MAI), Aberdeen Global Income Fund (FCO), MelodyVR Group (ASLR), TSE:PIC.A (PIC.A), EPE Special Opportunities (ESO), Microequities Asset Management Group (MAM), Wilmington Capital Management (WCM.A), Naos Emerging Opportunities (NCC), India Capital Growth Fund (IGC) and AMYF FIVE/ORD UNRESTR (AYZ). View all competitors. What other stocks do shareholders of Biopharma Credit own? Based on aggregate information from My MarketBeat watchlists, some companies that other Biopharma Credit investors own include African Potash (AFPO), Altius Minerals (ATUSF), LiDCO Group (LID), Satellite Solutions Worldwide (SAT), San Juan Basin Royalty Trust (SJT), ANGLE (AGL), International Paper (IP), SPX Flow (FLOW), Fulcrum Utility Services (FCRM) and DX (Group) (DX). Who are Biopharma Credit's key executives? Biopharma Credit's management team includes the following people: Mr. Pedro Gonzalez de Cosio, Investment Mang.Mr. Pablo G. Legorreta, Investment Mang.Mr. Martin G. Friedman, Investment Mang. (Age 54) What is Biopharma Credit's stock symbol? Biopharma Credit trades on the London Stock Exchange (LON) under the ticker symbol "BPCR." How do I buy shares of Biopharma Credit? Shares of BPCR and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Biopharma Credit's stock price today? One share of BPCR stock can currently be purchased for approximately GBX 0.99. How big of a company is Biopharma Credit? Biopharma Credit has a market capitalization of £13.66 million and generates £141.97 million in revenue each year. What is Biopharma Credit's official website? The official website for Biopharma Credit is www.bpcruk.com. This page was last updated on 7/15/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
